CTMS Upgrades to New Data Entry System

CTMS announces the upgrade to EntrypointTM as the new data entry system for all paper-based data management studies. By completing this upgrade, CTMS' data management systems are fully compliant with 21 CFR Part 11.

CTMS Welcomes New Business Development Manager.

CTMS is proud to announce Jeff Blum has joined CTMS as Business Development Manager. He is based in Raleigh, NC and will handle all new client development while working with Client Services and Corporate Affairs. Jeff comes to CTMS with 7 years industry experience in business development and is a Penn State graduate. To contact Jeff, please call 919-845-8279 or jblum@ctmsinc.com.

CTMS Participates in the 2004 Relay for Life Campaign.

CTMS is proud to have been a participant in the 2004 Relay for Life Campaign. The CTMS team began raising money in February and held at least one event each month, including: Chocolate Fest (February), Pancake Breakfast and Soup Luncheon (March), Easter Candy Fest and Girl's Night Out (April), a yard sale, Southern Fried Fun Day and Fruit and Cheese Day (May), and the annual CTMS picnic and basketball shootout in June. This is the sixth year that CTMS has participated in the walk and each year we have seen the anticipation and participation grow. We look forward to many more successful campaigns in the future! CTMS strives for excellence every day, not only in our business but in our communities as well.

CTMS Clinical Research Associate Co-Authors Article

Suzanne Boswell, CRA, co-authored an article entitled, “New Nurses’ Perceptions of Nursing Practice and Quality Patient Care,” which appears in the January-March 2004 Journal of Nursing Care Quality. Boswell joined CTMS as a CRA in June 2003.

CTMS Medical Director Published in Journals

CTMS Medical Director Sharon W. Moore, M.D. had two articles concerning biotechnology and drug development published in the December 2003 Southern Medical Journal.

1) The editorial was entitled, “Will Advances in Biotechnology Usher in a New Era of Medicine?” (South Med J 2003;96:1169-70.) It accompanied an article entitled, “Biotechnology and Drug Discovery: From Bench to Bedside” by Y Avidor, NJ Mabjeesh, and H Matzkin from Ethicon Endo-Surgery/Johnson & Johnson, Winship Cancer Institute/Emory University, and Tel Aviv Sourasky Medical Center/Tel Aviv, Israel.

2) The review article was entitled, “An Overview of Drug Development in the United States and Current Challenges” (South Med J 2003;96:1244-55.)

Dr. Moore holds a Bachelor of Arts (BA) in Chemistry and Biology, East Tennessee State University, Johnson City, Tennessee; a Masters of Public Health (MPH) degree in General Preventive Medicine & Public Health, Medical College of Wisconsin, Milwaukee, Wisconsin; a Masters in Business Administration (MBA), East Tennessee State University, Johnson City, Tennessee; and a Doctor of Medicine (M.D.) degree from Vanderbilt University School of Medicine, Nashville, Tennessee.

CTMS to Sponsor Partnerships with CROs, Orlando, Florida

CTMS will provide a phone card with 15 minutes of free long distance calls to each attendee of the 13th Annual Partnerships with CROs conference, to be held in Orlando, Florida April 25-28, 2004. In addition, CTMS will exhibit in Booth 200 of the Exhibit Hall during the conference. Partnerships with CROs has become the central gathering place for sponsors, contract research organizations, and other vendors, for the exchange of ideas and information. Over 750 attendees are expected at this conference.

CTMS to Exhibit at DIA, Washington, DC

For the 5th consecutive year, CTMS will exhibit at the Drug Information Association Annual Meeting, which will be held in Washington, DC, June 13-16-2004. Approximately 8,000 attendees are expected. CTMS will exhibit in Booth 555 in the Exhibit Hall of the DIA conference.

CTMS Announces Specialty Therapeutic Areas

For 14 years, CTMS, Inc. has been the CRO of choice of many sponsors. Through a comprehensive Strategic Planning process, CTMS has elected to move into the future by focusing on key therapeutic areas in which the company has the most experience. Those areas are respiratory, central nervous system (CNS), infectious diseases (HIV), ophthalmology, GI, and oncology.

“Sponsors have appreciated our quality for years and, more than ever, therapeutic expertise is desired by the pharmaceutical and biologics industries. We will not only focus our clinical operations in our top therapeutic areas but will become more visible at associated professional conferences,” stated Mac McElroy, Executive Director, Corporate Affairs.